loading
전일 마감가:
$5.71
열려 있는:
$5.78
하루 거래량:
120.19K
Relative Volume:
1.27
시가총액:
$248.01M
수익:
-
순이익/손실:
$-19.90M
주가수익비율:
-10.94
EPS:
-0.53
순현금흐름:
$-19.80M
1주 성능:
+15.54%
1개월 성능:
-9.52%
6개월 성능:
+78.46%
1년 성능:
+105.67%
1일 변동 폭
Value
$5.75
$6.14
1주일 범위
Value
$5.015
$6.14
52주 변동 폭
Value
$2.14
$6.41

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
명칭
Diamedica Therapeutics Inc
Name
전화
(763) 496-5454
Name
주소
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
직원
19
Name
트위터
@diamedica
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
DMAC's Discussions on Twitter

DMAC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
5.80 248.01M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-07 개시 H.C. Wainwright Buy
2024-04-24 재개 Craig Hallum Buy
2023-06-22 업그레이드 Oppenheimer Perform → Outperform
2021-04-09 개시 Oppenheimer Outperform
2021-02-17 개시 ROTH Capital Buy
2020-10-30 개시 Guggenheim Buy
2020-07-08 개시 Maxim Group Buy
2019-04-30 개시 Dougherty & Company Buy
2019-03-05 개시 Lake Street Buy
모두보기

Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스

pulisher
Jan 10, 2025

Geode Capital Management LLC Purchases 70,070 Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Jan 10, 2025
pulisher
Dec 29, 2024

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$43m - Simply Wall St

Dec 29, 2024
pulisher
Dec 29, 2024

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Increase in Short Interest - MarketBeat

Dec 29, 2024
pulisher
Dec 29, 2024

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Up 28.4% in December - Defense World

Dec 29, 2024
pulisher
Dec 20, 2024

Diamedica Stock Soars to 52-Week High, Hits $6.41 - Investing.com

Dec 20, 2024
pulisher
Dec 19, 2024

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m - Yahoo Finance

Dec 19, 2024
pulisher
Dec 15, 2024

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Declines By 12.2% - MarketBeat

Dec 15, 2024
pulisher
Dec 12, 2024

Diamedica Stock Soars to 52-Week High, Reaching $5.74 - Investing.com

Dec 12, 2024
pulisher
Dec 12, 2024

Diamedica Stock Soars to 52-Week High, Reaching $5.74 By Investing.com - Investing.com UK

Dec 12, 2024
pulisher
Dec 07, 2024

DiaMedica Therapeutics (NASDAQ:DMAC) Trading 0.6% HigherHere's What Happened - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

DiaMedica Therapeutics (NASDAQ:DMAC) Trading 0.6% Higher – Should You Buy? - Defense World

Dec 07, 2024
pulisher
Dec 04, 2024

Amneal to Participate at Upcoming Investor Conferences - Business Wire

Dec 04, 2024
pulisher
Dec 03, 2024

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia - BioSpace

Dec 03, 2024
pulisher
Dec 03, 2024

DiaMedica Therapeutics management to meet virtually with Lake Street - Nasdaq

Dec 03, 2024
pulisher
Dec 03, 2024

DiaMedica Forms Elite Scientific Advisory Board for Preeclampsia Treatment Development - StockTitan

Dec 03, 2024
pulisher
Dec 02, 2024

Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders at the 66th ASH Annual Meeting and Exposition - Business Wire

Dec 02, 2024
pulisher
Nov 26, 2024

DMAC Stock Soars to 52-Week High, Hits $4.95 Amid Bullish Run - Investing.com

Nov 26, 2024
pulisher
Nov 23, 2024

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation - Simply Wall St

Nov 23, 2024
pulisher
Nov 16, 2024

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

HC Wainwright Reaffirms Buy Rating for DiaMedica Therapeutics (NASDAQ:DMAC) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 14, 2024

DiaMedica Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

DMACDiaMedica Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results - BioSpace

Nov 14, 2024
pulisher
Nov 13, 2024

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia - Business Wire

Nov 13, 2024
pulisher
Nov 13, 2024

DiaMedica Launches Phase 2 Trial for Novel Preeclampsia Treatment DM199 - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

DiaMedica (DMAC) to Present at Craig-Hallum Conference: Spotlight on DM199 Stroke Treatment | DMAC Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference - Yahoo Finance

Nov 12, 2024
pulisher
Nov 07, 2024

DiaMedica Therapeutics (DMAC) Set to Announce Quarterly Earnings on Wednesday - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

CRH plc (the "Company") Form 10-Q for the quarterly period ended September 30, 2024 - Business Wire

Nov 07, 2024
pulisher
Nov 06, 2024

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024 - BioSpace

Nov 06, 2024
pulisher
Oct 27, 2024

Blue Trust Inc. Makes New Investment in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Oct 27, 2024
pulisher
Oct 15, 2024

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Large Growth in Short Interest - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Best Momentum Stocks to Buy for October 14th - Yahoo Canada Finance

Oct 14, 2024
pulisher
Oct 13, 2024

Head to Head Contrast: DiaMedica Therapeutics (NASDAQ:DMAC) versus Provectus Biopharmaceuticals (OTCMKTS:PVCT) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

DiaMedica shares maintain Buy rating from H.C. Wainwright - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

DiaMedica shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com South Africa

Oct 10, 2024
pulisher
Oct 10, 2024

DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

DiaMedica advances preeclampsia treatment with trial approval By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 09, 2024

DiaMedica advances preeclampsia treatment with trial approval - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia - Business Wire

Oct 09, 2024
pulisher
Oct 09, 2024

Research Analysts Offer Predictions for DiaMedica Therapeutics Inc.'s Q3 2024 Earnings (NASDAQ:DMAC) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

KaliVir Immunotherapeutics Doses First Patient in Phase 1/1b Trial of VET3-TGI for Incurable, Advanced, Solid Tumors - Business Wire

Oct 08, 2024
pulisher
Oct 07, 2024

H.C. Wainwright initiates DiaMedica shares with Buy rating on stroke treatment By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

H.C. Wainwright initiates DiaMedica shares with Buy rating on stroke treatment - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

DiaMedica Therapeutics (NASDAQ:DMAC) Coverage Initiated by Analysts at HC Wainwright - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Oct 07, 2024
pulisher
Oct 04, 2024

DiaMedica: Readying For REDUX Readout - RTTNews

Oct 04, 2024
pulisher
Oct 01, 2024

Magnolia Capital Advisors LLC Buys New Stake in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Modalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD) - Business Wire

Sep 30, 2024
pulisher
Sep 24, 2024

Point72 DIFC Ltd Acquires Shares of 2,848 Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 24, 2024

Diamedica Therapeutics Inc (DMAC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
자본화:     |  볼륨(24시간):